Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,493,510
+$6,641,785 QoQ
Shares Held
91,279
+338.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 282 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$109,190
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. BNTX ranks #24 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676,247 | $335,912,169 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
382,028 | $238,209,735 | |
| 3 | INCY |
Incyte Corp
|
1,307,743 | $148,245,744 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,224,925 | $68,681,542 | |
| 5 | MRNA |
Moderna, Inc.
|
636,199 | $44,553,014 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
115,279 | $34,702,435 | |
| 7 | INSM |
INSMED Inc
|
279,961 | $29,849,438 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
307,543 | $17,597,610 |
All Filings in BNTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,493,510 | 91,279 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,851,725 | 20,834 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $4,976,960 | 52,279 | Shares | Defined | 2026-03-06 | |
| 2023-03-31 | $227,214 | 1,824 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $268,593 | 1,788 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $301,591 | 2,236 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,751,817 | 31,870 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,003,745 | 5,885 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $342,100 | 1,327 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,105,571 | 7,713 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,032,310 | 4,611 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $669,116 | 6,128 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $109,190 | 1,000 | Put | Defined | 2021-05-14 | |
| 2020-12-31 | $1,446,246 | 17,741 | Shares | Defined | 2021-02-25 | |
| 2020-09-30 | $4,614,664 | 66,657 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||